FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283209455> ?p ?o ?g. }

• W4283209455 endingPage "103756" @default.
• W4283209455 startingPage "103756" @default.
• W4283209455 abstract "Though synthetic cannabinoid receptor agonists (SCRAs) were controlled after being introduced as a ‘legal high,’ SCRAs likely remain appealing to individuals subject to routine drug screens as not all testing programs consistently include SCRAs. Military populations have been linked to SCRAs due to the unconfirmed supposition that testing protocols led many to substitute SCRAs for cannabis. This study aimed to explore SCRA use prevalence, correlates, and use motivations among veterans, with a particular focus on whether United States military personnel substituted SCRAs for cannabis to subvert testing protocols. All veterans appearing in one of eight civilian criminal courts in three U.S. states were invited to answer questionnaire items related to military service, court functionality, and substance use. Of the 579 veterans eligible, 54.9% chose to participate, yielding a cross-sectional sample of 318 veterans charged with a criminal offense by civilian authorities. Sixty-five (21.3%) justice-involved veterans reported lifetime SCRA use. Use while within the military was reported by 15.0% of veterans enlisting after 2008. Only eight (12.3%) reported SCRAs were used as a substitute for cannabis. Boredom (36.9%), experimentation (27.7%), and social aspects of SCRA use (32.3%) were more commonly reported motives. Logistic regression models indicated that use of cannabis (aPR=2.06, p<.05), hallucinogens (aPR=2.50, p<.01), and SCRAs (aPR=2.49, p<.05) while in the military were risk factors for SCRA use after leaving the military, whereas older age at time of military exist was a protective factor (aPR=.87, p<.01) Drug testing programs within the military do not appear to have the unintended consequence of routing individuals to more risky drugs; however, SCRAs appear to have been an underappreciated problem within the military. Further, use extends beyond the military with many only initiating use after discharge, suggesting SCRA use may jeopardize the health of veterans post-service." @default.
• W4283209455 created "2022-06-22" @default.
• W4283209455 creator A5017353846 @default.
• W4283209455 creator A5020861941 @default.
• W4283209455 creator A5053295238 @default.
• W4283209455 date "2022-08-01" @default.
• W4283209455 modified "2023-09-27" @default.
• W4283209455 title "Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans" @default.
• W4283209455 cites W1495188205 @default.
• W4283209455 cites W1507713155 @default.
• W4283209455 cites W1541161700 @default.
• W4283209455 cites W1541287645 @default.
• W4283209455 cites W1840072893 @default.
• W4283209455 cites W1868149644 @default.
• W4283209455 cites W1883661543 @default.
• W4283209455 cites W1964551036 @default.
• W4283209455 cites W1967724789 @default.
• W4283209455 cites W1975974937 @default.
• W4283209455 cites W1981834714 @default.
• W4283209455 cites W1991083132 @default.
• W4283209455 cites W1997982382 @default.
• W4283209455 cites W2007661556 @default.
• W4283209455 cites W2009801264 @default.
• W4283209455 cites W2052638982 @default.
• W4283209455 cites W2059713190 @default.
• W4283209455 cites W2064500825 @default.
• W4283209455 cites W2064958196 @default.
• W4283209455 cites W2074114778 @default.
• W4283209455 cites W2079890760 @default.
• W4283209455 cites W2080450585 @default.
• W4283209455 cites W2093524538 @default.
• W4283209455 cites W2096764558 @default.
• W4283209455 cites W2106689044 @default.
• W4283209455 cites W2114835930 @default.
• W4283209455 cites W2115346273 @default.
• W4283209455 cites W2148106249 @default.
• W4283209455 cites W2163669209 @default.
• W4283209455 cites W2169744461 @default.
• W4283209455 cites W2174666374 @default.
• W4283209455 cites W2178564482 @default.
• W4283209455 cites W2202639059 @default.
• W4283209455 cites W2225112609 @default.
• W4283209455 cites W2289451715 @default.
• W4283209455 cites W2298378217 @default.
• W4283209455 cites W2300958066 @default.
• W4283209455 cites W2308080184 @default.
• W4283209455 cites W2314504745 @default.
• W4283209455 cites W2339757520 @default.
• W4283209455 cites W2402856502 @default.
• W4283209455 cites W2406189770 @default.
• W4283209455 cites W2408308093 @default.
• W4283209455 cites W2516143102 @default.
• W4283209455 cites W2551235610 @default.
• W4283209455 cites W2738591180 @default.
• W4283209455 cites W2779687529 @default.
• W4283209455 cites W2784158742 @default.
• W4283209455 cites W2891450331 @default.
• W4283209455 cites W2906293067 @default.
• W4283209455 cites W2911608221 @default.
• W4283209455 cites W2916161759 @default.
• W4283209455 cites W2918096590 @default.
• W4283209455 cites W2946996561 @default.
• W4283209455 cites W2965679873 @default.
• W4283209455 cites W2981398621 @default.
• W4283209455 cites W2981844663 @default.
• W4283209455 cites W2994973793 @default.
• W4283209455 cites W3010279514 @default.
• W4283209455 cites W3014439409 @default.
• W4283209455 cites W3016243178 @default.
• W4283209455 cites W3020757641 @default.
• W4283209455 cites W3022664791 @default.
• W4283209455 cites W3040252364 @default.
• W4283209455 cites W3088381050 @default.
• W4283209455 cites W3092646199 @default.
• W4283209455 cites W3107342186 @default.
• W4283209455 cites W3112564761 @default.
• W4283209455 cites W3121948652 @default.
• W4283209455 cites W3130827012 @default.
• W4283209455 cites W3160009347 @default.
• W4283209455 doi "https://doi.org/10.1016/j.drugpo.2022.103756" @default.
• W4283209455 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35738030" @default.
• W4283209455 hasPublicationYear "2022" @default.
• W4283209455 type Work @default.
• W4283209455 citedByCount "4" @default.
• W4283209455 countsByYear W42832094552022 @default.
• W4283209455 countsByYear W42832094552023 @default.
• W4283209455 crossrefType "journal-article" @default.
• W4283209455 hasAuthorship W4283209455A5017353846 @default.
• W4283209455 hasAuthorship W4283209455A5020861941 @default.
• W4283209455 hasAuthorship W4283209455A5053295238 @default.
• W4283209455 hasConcept C102587632 @default.
• W4283209455 hasConcept C118552586 @default.
• W4283209455 hasConcept C126322002 @default.
• W4283209455 hasConcept C151956035 @default.
• W4283209455 hasConcept C15744967 @default.
• W4283209455 hasConcept C17744445 @default.
• W4283209455 hasConcept C199539241 @default.
• W4283209455 hasConcept C2776948989 @default.

• next